Morphological indices and patterns of acid-fast bacilli from multiple sites were not correlated with IL-10, PGE2, and IL-35 levels in multibacillary leprosy patients

Authors

  • Fitriyanti Department of Dermatology, Venereology, and Aesthetics, Universitas Jambi, Jambi, Indonesia
  • Lipinwati Department of Microbiology and Parasitology, Universitas Jambi, Jambi, Indonesia
  • Attiya Istarini Department of Neurology, Universitas Jambi, Jambi, Indonesia
  • Tia Wida Ekaputri Department of Biomedical Sciences, Universitas Jambi, Indonesia
  • Niken Irfa Nastiti Department of Dermatology, Venereology, and Aesthetics, Universitas Jambi, Jambi, Indonesia

DOI:

https://doi.org/10.55681/armada.v4i10.4181

Keywords:

Leprosy, Lepromatous, Mycobacterium leprae, Interleukin-10, Dinoprostone, T-Lymphocytes

Abstract

Multibacillary leprosy is characterized by a high bacterial load and a tolerogenic immune profile involving interleukin-10 (IL-10), prostaglandin E2 (PGE2), and interleukin-35 (IL-35). Previous studies relied solely on the aggregate bacterial index, without accounting for bacillary distribution across body sites or viability, reflected in the morphological index. This study analyzed relationships between the morphological index and acid-fast bacilli (AFB) patterns at six sites and serum IL-10, PGE2, and IL-35 levels in multibacillary leprosy patients in Banyuasin Regency, South Sumatra, using a cross-sectional design. The morphological index and AFB grade at both ears, hands, and feet were examined via skin scraping. IL-10 and PGE2 levels were measured in 30 patients, and IL-35 levels in 29 patients. Five bacteriological metrics were correlated with the three immune markers using Spearman's correlation, with P values corrected using the Benjamini-Hochberg method. Of the fifteen pairs tested, none were significant after correction (corrected P 0.96-0.97). The strongest correlation was between the number of positive smear sites and PGE2 (rho -0.27, P = 0.16), with a confidence interval crossing zero. The morphological index and multisite AFB patterns were not associated with IL-10, PGE2, or IL-35. Larger studies are needed to confirm these associations.

Downloads

Download data is not yet available.

Author Biographies

Fitriyanti, Department of Dermatology, Venereology, and Aesthetics, Universitas Jambi, Jambi, Indonesia

Department of Dermatology, Venereology, and Aesthetics, Universitas Jambi

Lipinwati, Department of Microbiology and Parasitology, Universitas Jambi, Jambi, Indonesia

Department of Microbiology and Parasitology, Universitas Jambi

Attiya Istarini, Department of Neurology, Universitas Jambi, Jambi, Indonesia

Department of Neurology, Universitas Jambi, Jambi

Tia Wida Ekaputri, Department of Biomedical Sciences, Universitas Jambi, Indonesia

Department of Biomedical Sciences, Universitas Jambi

Niken Irfa Nastiti, Department of Dermatology, Venereology, and Aesthetics, Universitas Jambi, Jambi, Indonesia

Department of Microbiology and Parasitology, Universitas Jambi

References

Cabral, N., de Figueiredo, V., Gandini, M., de Souza, C. F., Medeiros, R. A., Lery, L. M. S., Lara, F. A., de Macedo, C. S., Pessolani, M. C. V., & Pereira, G. M. B. (2022). Modulation of the response to Mycobacterium leprae and pathogenesis of leprosy. Frontiers in Microbiology, 13, 918009. https://doi.org/10.3389/fmicb.2022.918009

Chen, S., Saeed, A. F. U. H., Liu, Q., Jiang, Q., Xu, H., Xiao, G. G., Rao, L., & Duo, Y. (2023). Macrophages in immunoregulation and therapeutics. Signal Transduction and Targeted Therapy, 8(1), 207. https://doi.org/10.1038/s41392-023-01452-1

Couper, K. N., Blount, D. G., & Riley, E. M. (2008). IL-10: The master regulator of immunity to infection. Journal of Immunology, 180(9), 5771–5777. https://doi.org/10.4049/jimmunol.180.9.5771

Deps, P. D., Kahawita, I., Yotsu, R., & Lambert, S. M. (2025). Leprosy research updates: Shaping the future of global health. Indian Journal of Medical Research, 161, 120. https://doi.org/10.25259/IJMR_195_2025

Fitriyanti, Lipinwati, Istarini, A., Ekaputri, T. W., Nastiti, N. I., & Adnyana, I. M. D. M. (2025). Correlation of IL-10 levels with the bacterial index in multibacillary leprosy. Jambi Medical Journal, 13(2), 239–245. https://doi.org/10.22437/jmj.v13i2.48898

Fitriyanti, Lipinwati, Istarini, A., Ekaputri, T. W., Nastiti, N. I., Adnyana, I. M. D. M., & Pratiwi, R. (2026). The –819 T/C polymorphism in the interleukin-10 gene promoter modulates IL-10 levels independently of PGE2 in multibacillary leprosy. Nursing and Health Sciences Journal, 6(2), 314–327. https://doi.org/10.53713/nhsj.v6i2.684

Grijsen, M. L., Nguyen, T. H., Pinheiro, R. O., Singh, P., Lambert, S. M., Walker, S. L., & Geluk, A. (2024). Leprosy. Nature Reviews Disease Primers, 10(1), 90. https://doi.org/10.1038/s41572-024-00575-1

Kimta, N., Majdalawieh, A. F., Nasrallah, G. K., Puri, S., Nepovimova, E., Jomova, K., & Kuča, K. (2024). Leprosy: Comprehensive insights into pathology, immunology, and cutting-edge treatment strategies, integrating nanoparticles and ethnomedicinal plants. Frontiers in Pharmacology, 15, 1361641. https://doi.org/10.3389/fphar.2024.1361641

Liu, C., Workman, C. J., & Vignali, D. A. A. (2016). Targeting regulatory T cells in tumors. FEBS Journal, 283(14), 2731–2748. https://doi.org/10.1111/febs.13656

Lubis, R. S., Anum, Q., Argentina, F., Menaldi, S. L., Gunawan, H., Yuniati, R., Mulianto, N. R., Siswati, A. S., Widasmara, D., Rusyati, L. M. M., Mamuaja, E. H., Muchtar, V., Prakoeswa, C. R. S., Agusni, R. I., Kusumaputra, B. H., Alinda, M. D., & Listiawan, M. Y. (2022). Epidemiology of leprosy in Indonesia: A retrospective study. Journal of Dermatology and Venereology, 34(1), 29–35. https://doi.org/10.20473/bikk.V34.1.2022.29-35

Malhotra, K. P., & Husain, N. (2022). Laboratory perspectives on leprosy: Diagnostic, prognostic, and predictive tools. Indian Journal of Pathology and Microbiology, 65(5), 300–309. https://doi.org/10.4103/ijpm.ijpm_1083_21

Nath, I. (2016). Immunopathogenesis of leprosy: A model for T-cell anergy. EMJ Dermatology, 4(1), 95–101. https://doi.org/10.33590/emjdermatol/10312914

Saini, C., Ramesh, V., & Nath, I. (2014). Increase in TGF-β-secreting CD4+CD25+FOXP3+ T regulatory cells in anergic lepromatous leprosy patients. PLOS Neglected Tropical Diseases, 8(7), e2639. https://doi.org/10.1371/journal.pntd.0002639

Sebong, P. H., Ferdiana, A., Tegu, F. A. R., Harbianto, D., Soviandhi, R., Sinaga, A., Budiawan, T., Risnanto, A. J. A. Y., Sidjabat, R. T., Yudopuspito, T., Mawardi, R., Setyawati, E., & Utarini, A. (2025). Participatory development of Indonesia’s national action plan for zero leprosy: Strategies and interventions. Frontiers in Public Health, 13, 1453470. https://doi.org/10.3389/fpubh.2025.1453470

Silva, M. J., Silva, C. S., Brasil, T. P., Alves, A. K., Dos Santos, E. C., Frota, C. C., Lima, K. V., & Lima, L. N. (2024). An update on leprosy immunopathogenesis: Systematic review. Frontiers in Immunology, 15, 1416177. https://doi.org/10.3389/fimmu.2024.1416177

Tarique, M., Saini, C., Naqvi, R. A., Khanna, N., & Rao, D. N. (2017). Increased IL-35-producing Tregs and CD19+IL-35+ cells are associated with disease progression in leprosy patients. Cytokine, 91, 82–88. https://doi.org/10.1016/j.cyto.2016.12.011

Wang, W., Pan, K., Yang, J., & Li, Z. (2025). Prostaglandin E2 (PGE2) in tissue regeneration: Its role and therapeutic strategies. EXCLI Journal, 24, 1634–1656. https://doi.org/10.17179/excli2025-9025

Downloads

Published

2026-10-31

How to Cite

Fitriyanti, Lipinwati, Istarini, A., Ekaputri, T. W., & Nastiti, N. I. (2026). Morphological indices and patterns of acid-fast bacilli from multiple sites were not correlated with IL-10, PGE2, and IL-35 levels in multibacillary leprosy patients. ARMADA : Jurnal Penelitian Multidisiplin, 4(10), 6243–6254. https://doi.org/10.55681/armada.v4i10.4181